The strategy of rational approaches to the search for selective COX-2 inhibitors as potential antiinflammatory agents has been proposed and elaborated. It is based on the use of PASS-prediction and molecular docking. The choice of the basic structure of 4-amino-3-thio-1,2,4-triazole as a promising object of chemical modification has been substantiated. Using a modification of the primary molecule, a virtual library of S-derivatives of 5-substituted 4-amino(pyrrol)3-thio-4H-1,2,4-triazoles in the amount of 100 compounds (ten groups) has been obtained by introducing various pharmacophore fragments. Based on the analysis of the results of the PASS-prediction and molecular docking, six of the ten planned groups of compounds have been selected for the synthesis as promising selective COX-2 inhibitors. The reliability of the prediction results has already been confirmed for one of the promising group 4-amino-5-(pyridine-4-yl)-1,2,4-triazole (4Н)-3-yl-thioacetamides.
Full text article
Cai, H., Huang, X., Xu, S., Shen, H., Zhang, P., Huang, Y., Jiang, J., Sun, Y., Jiang, B., Wu, X., Yao, H., & Xu, J. (2016). Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy. European Journal of Medicinal Chemistry, 108, 89-103. doi: 10.1016/j.ejmech.2015.11.013
Chalenko, N.M., Demchenko, A.M., & Syrovaya, G.O. (2019). Synthesis and biological activity of 4-amino-5-(pyridin-4-yl)-1,2,4-triazole(4H)-3-il-thioacetamides. Actual problems of experimental and clinical biochemistry: materials of the international scientific-practical conference (p. 79). Kharkiv, Ukraine: Kharkiv National Medical University.
Chalenko, N.M. & Syrovaya, G.O. (2017). The feasibility of using the prediction of activity spectra for substances program for targeted synthesis of potential non-steroidal class 3-thio-1,2,4-triazoles. Bioethics and Biosafety: Multidisciplinary Aspects: Materials of a Scientific and Practical Conference with International Participation dedicated to the 105th Anniversary of V.K. Viskovich (pp. 160-161). Kharkiv, Ukraine: Kharkiv National Medical University.
Cordero, J.A., Camacho, M., Obach, R., Domenech, J., & Vila, L. (2001). In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. European Journal of Pharmaceutics and Biopharmaceutics, 51(2), 135-142. doi: 10.1016/s0939-6411(00)00149-1
Jiang, B., Zeng, Y., Li, M.J., Xu, J.Y., Zhang, Y.N., Wang, Q.J., Sun, N.Y., Lu, T., & Wu, X.M. (2010). Design, synthesis, and biological evaluation of 1,5-diaryl-1,2,4-triazole derivatives as selective cyclooxygenase-2 inhibitors. Archiv der Pharmazie, 343(9), 500-508. doi: 10.1002/ardp.200900227
Jin, J.Y., Zhang, L.X., Zhang, A.J., Lei, X.X., & Zhu, J.H. (2007). Synthesis and Biological Activity of Some Novel Derivatives of 4-Amino-3-(D-galactopentitol-1-yl)-5-mercapto-1,2,4-triazole. Molecules, 12(8), 1596-1605. doi: 10.3390/12081596
Khanage, S.G., Raju, S.A., Mohite, P.B., & Pandhare, R.B. (2012). Synthesis and Pharmacological Evaluation of Some New Pyrimidine Derivatives Containing 1,2,4-Triazole. Advanced Pharmaceutical Bulletin, 2(2), 213-222. doi: 10.5681/apb.2012.033
Kurumbail, R.G., Stevens, A.M., Gierse, J.K., McDonald, J.J., Stegeman, R.A., Pak, J.Y., Gildehaus, D., Miyashiro, J.M., Penning, T.D., Seibert, K., Isakson, P.C., & Stallings, W.C. (1997). Correction: Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature, 385, 555. doi: 10.1038/385555b0
Lagunin, A., Stepanchikova, A., Filimonov, D., & Poroikov, V. (2000). PASS: prediction of activity spectra for biologically active substances. Bioinformatics, 16(8), 747-748. doi: 10.1093/bioinformatics/16.8.747
Laube, M., Kniess, T., & Pietzsch, J. (2016). Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review. Antioxidants, 5(2), 14. doi: 10.3390/antiox5020014
Leelananda, S.P. & Lindert, S. (2016). Computational methods in drug discovery. Beilstein Journal of Organic Chemistry, 12, 2694-2718. doi: 10.3762/bjoc.12.267
Mioc, M., Soica, C., Bercean, V., Avram, S., Balan-Porcarasu, M., Coricovac, D., Ghiulai, R., Muntean, D., Andrica, F., Dehelean, C., Spandidos, D.A., Tsatsakis, A.M., & Kurunczi, L. (2017). Design, synthesis and pharmaco-toxicological assessment of 5-mercapto-1,2,4-triazole derivatives with antibacterial and antiproliferative activity. International Journal of Oncology, 50(4), 1175-1183. doi: 10.3892/ijo.2017.3912
Moise, M., Sunel, V., Profire, L., Popa, M., Desbrieres, J., & Peptu, C. (2009). Synthesis and Biological Activity of Some New 1,3,4-Thiadiazole and 1,2,4-Triazole Compounds Containing a Phenylalanine Moiety. Molecules, 14(7), 2621-2631. doi: 10.3390/molecules14072621
Mozziconacci, J.C., Arnoult, E., Bernard, P., Do, Q.T., Marot, C., & Morin-Allory, L. (2005). Optimization and validation of a docking-scoring protocol; application to virtual screening for COX-2 inhibitors. Journal of Medicinal Chemistry, 48(4), 1055-1068. doi: 10.1021/jm049332v
Oliveira, J.W.F., Rocha, H.A.O., de Medeiros, W.M.T.Q., & Silva, M.S. (2019). Application of Dithiocarbamates as Potential New Antitrypanosomatids-Drugs: Approach Chemistry, Functional and Biological. Molecules, 24(15), 2806. doi: 10.3390/molecules24152806
Parasuraman, S. (2011). Prediction of activity spectra for substances. Journal of Pharmacology and Pharmacotherapeutics, 2(1), 52-53. doi: 10.4103/0976-500X.77119
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe Jr., E.W. (2014). Computational Methods in Drug Discovery. Pharmacological Reviews, 66(1), 334-395. doi: 10.1124/pr.112.007336
Sondhi, S.M., Dinodia, M., Singh, J., & Rani, R. (2007). Heterocyclic Compounds as Anti-Inflammatory Agents. Current Bioactive Compounds, 3(2), 91-108. doi: 10.2174/157340707780809554
Torres, P.H.M., Sodero, A.C.R., Jofily, P., & Silva Jr., F.P. (2019). Key Topics in Molecular Docking for Drug Design. International Journal of Molecular Sciences, 20(18), 4574. doi: 10.3390/ijms20184574
Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017). Chalcone: A Privileged Structure in Medicinal Chemistry. Chemical Reviews, 117(12), 7762-7810. doi: 10.1021/acs.chemrev.7b00020
Copyright (c) 2020 Natalya Mykolayivna Chalenko, Anna Olegovna Syrovaya, Natalya P Kobzar, Maryna V Rakhimova, Irina A Sych, Igor Vladimirovich Sych
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions.
Authors who publish with this journal agree to the following terms:
- Any article on the copyright is retained by the author(s).
- The author grants the journal, right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles of work (eg, post-institutional repository) or publish it in a book, with acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process, as can lead to productive exchanges, as well as earlier and greater citation of published work.
- The article and any associated published material are distributed under the Creative Commons Attribution-ShareAlike 4.0 International License.